Prev：Development of a monoclonal antibody against PRRSV glycoprotein 3 using an immuodominant peptide as immunogen(A21010-5.162)
Next：G-CSF reduces loss of dopaminergic neurons by inhibiting TNF-α and IL-1β in mouse model of Parkinson's disease(A23220-2.107)
